Different studies reported MDS transformation to AML with a frequency between 6% [72,82] and 12.8% [91]; one possible explanation may be the simultaneous presence of deletion 5q and JAK2 V617F gene mutation and other gene mutations (for example, TP53). The gene discussed is JAK2; the disease is myelodysplastic syndrome.